XOMA Royalty Corp.
NASDAQ:XOMABiotechnology
+$0.19 today
- Market cap
- $503.77M
- Beta
- 0.87
- P/E (TTM)
- 15.8
- EPS (TTM)
- $2.65
Volume 4.22M
Average 0.21M
Dividends
XOMA Royalty Corp. dividends
Review the payout history, yield, and how well earnings and cash flow support the dividend.
Dividends
Dividend history, growth & yield
Yield
0.00%
Annual Div/Share
$2.16
Payout Ratio
17.5%
Frequency
—
Shareholder Yield
4.27%
Next Ex-Date
Not announced
Next Payment
—
Analysis
The current indicated dividend yield is 0.00%. The payout ratio is 17.5%, so compare payout growth against earnings coverage.
Competitor dividends
How does XOMA Royalty Corp. compare as an income stock?
Compare dividend yield, payout ratios, and buybacks with similar companies.
Competitor Dividends
Peer payout, dividend, and buyback comparison
| Company | Market Cap | Dividend Yield | Annual Dividend | Payout Ratio | Buyback Yield |
|---|---|---|---|---|---|
Design Therapeutics, Inc. NASDAQ:DSGN | $976.83M | 0.00% | $0.00 | 0.00% | 0.00% |
Solid Biosciences Inc. NASDAQ:SLDB | $844.55M | 0.00% | $0.00 | 0.00% | 0.00% |
Aura Biosciences, Inc. NASDAQ:AURA | $496.91M | 0.00% | $0.00 | 0.00% | 0.00% |
Autolus Therapeutics plc NASDAQ:AUTL | $420.51M | 0.00% | $0.00 | 0.00% | 0.00% |
Rocket Pharmaceuticals, Inc. NASDAQ:RCKT | $419.30M | 0.00% | $0.00 | 0.00% | 0.00% |
DiaMedica Therapeutics Inc. NASDAQ:DMAC | $410.59M | 0.00% | $0.00 | 0.00% | 0.00% |
Benitec Biopharma Inc. NASDAQ:BNTC | $346.99M | 0.00% | $0.00 | 0.00% | 0.00% |
Galectin Therapeutics Inc. NASDAQ:GALT | $297.01M | 0.00% | $0.00 | -0.23% | 0.00% |
Quantum-Si incorporated NASDAQ:QSI | $184.05M | 0.00% | $0.00 | 0.00% | 0.00% |
Questions
Dividend questions
Common questions about XOMA's dividend, answered from reported figures.
Does XOMA stock pay dividends?
XOMA Royalty Corp. (XOMA) currently pays a dividend. The indicated dividend per share is 2.16 USD and the dividend yield is 0.00%.
Is XOMA's dividend covered?
The payout ratio is 17.5%, so compare that against earnings and free cash flow before relying on the dividend.
Continue the stock analysis
Jump to another research area for this company.